Cargando…
Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd on behalf of The British Infection Association.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743815/ https://www.ncbi.nlm.nih.gov/pubmed/35016901 http://dx.doi.org/10.1016/j.jinf.2022.01.002 |
| _version_ | 1784629994662658048 |
|---|---|
| author | Faustini, Sian Shields, Adrian Banham, Gemma Wall, Nadezhda Al-Taei, Saly Tanner, Chloe Ahmed, Zahra Efstathiou, Elena Townsend, Neal Goodall, Margaret Plant, Tim Perez-Toledo, Marisol Jasiulewicz, Aleksandra Price, Ruth McLaughlin, James Farnan, John Moore, Julie Robertson, Louise Nesbit, Andrew Curry, Grace Black, Amy Cunningham, Adam Harper, Lorraine Moore, Tara Drayson, Mark Richter, Alex |
| author_facet | Faustini, Sian Shields, Adrian Banham, Gemma Wall, Nadezhda Al-Taei, Saly Tanner, Chloe Ahmed, Zahra Efstathiou, Elena Townsend, Neal Goodall, Margaret Plant, Tim Perez-Toledo, Marisol Jasiulewicz, Aleksandra Price, Ruth McLaughlin, James Farnan, John Moore, Julie Robertson, Louise Nesbit, Andrew Curry, Grace Black, Amy Cunningham, Adam Harper, Lorraine Moore, Tara Drayson, Mark Richter, Alex |
| author_sort | Faustini, Sian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8743815 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Ltd on behalf of The British Infection Association. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87438152022-01-10 Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals Faustini, Sian Shields, Adrian Banham, Gemma Wall, Nadezhda Al-Taei, Saly Tanner, Chloe Ahmed, Zahra Efstathiou, Elena Townsend, Neal Goodall, Margaret Plant, Tim Perez-Toledo, Marisol Jasiulewicz, Aleksandra Price, Ruth McLaughlin, James Farnan, John Moore, Julie Robertson, Louise Nesbit, Andrew Curry, Grace Black, Amy Cunningham, Adam Harper, Lorraine Moore, Tara Drayson, Mark Richter, Alex J Infect Letter to the Editor Published by Elsevier Ltd on behalf of The British Infection Association. 2022-04 2022-01-10 /pmc/articles/PMC8743815/ /pubmed/35016901 http://dx.doi.org/10.1016/j.jinf.2022.01.002 Text en Crown Copyright © 2022 Published by Elsevier Ltd on behalf of The British Infection Association. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Faustini, Sian Shields, Adrian Banham, Gemma Wall, Nadezhda Al-Taei, Saly Tanner, Chloe Ahmed, Zahra Efstathiou, Elena Townsend, Neal Goodall, Margaret Plant, Tim Perez-Toledo, Marisol Jasiulewicz, Aleksandra Price, Ruth McLaughlin, James Farnan, John Moore, Julie Robertson, Louise Nesbit, Andrew Curry, Grace Black, Amy Cunningham, Adam Harper, Lorraine Moore, Tara Drayson, Mark Richter, Alex Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals |
| title | Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals |
| title_full | Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals |
| title_fullStr | Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals |
| title_full_unstemmed | Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals |
| title_short | Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals |
| title_sort | cross reactivity of spike glycoprotein induced antibody against delta and omicron variants before and after third sars-cov-2 vaccine dose in healthy and immunocompromised individuals |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743815/ https://www.ncbi.nlm.nih.gov/pubmed/35016901 http://dx.doi.org/10.1016/j.jinf.2022.01.002 |
| work_keys_str_mv | AT faustinisian crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals AT shieldsadrian crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals AT banhamgemma crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals AT wallnadezhda crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals AT altaeisaly crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals AT tannerchloe crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals AT ahmedzahra crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals AT efstathiouelena crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals AT townsendneal crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals AT goodallmargaret crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals AT planttim crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals AT pereztoledomarisol crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals AT jasiulewiczaleksandra crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals AT priceruth crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals AT mclaughlinjames crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals AT farnanjohn crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals AT moorejulie crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals AT robertsonlouise crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals AT nesbitandrew crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals AT currygrace crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals AT blackamy crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals AT cunninghamadam crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals AT harperlorraine crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals AT mooretara crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals AT draysonmark crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals AT richteralex crossreactivityofspikeglycoproteininducedantibodyagainstdeltaandomicronvariantsbeforeandafterthirdsarscov2vaccinedoseinhealthyandimmunocompromisedindividuals |